Review: taking Citalopram hydrobromide and Marijuana together


Summary

Drug interactions are reported among people who take Citalopram hydrobromide and Marijuana together. This review analyzes the effectiveness and drug interactions between Citalopram hydrobromide and Marijuana. It is created by eHealthMe based on reports of 220 people who take the same drugs from FDA and social media, and is updated regularly.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Citalopram Hydrobromide

Citalopram hydrobromide has active ingredients of citalopram hydrobromide. It is often used in depression. (latest outcomes from Citalopram hydrobromide 25,687 users)

Marijuana

Marijuana has active ingredients of marijuana. It is often used in drug abuse and dependence. (latest outcomes from Marijuana 2,735 users)

On Sep, 19, 2016

220 people who take Citalopram Hydrobromide, Marijuana are studied.


Number of reports submitted per year:

Citalopram hydrobromide and Marijuana drug interactions.

Drug effectiveness over time:

Citalopram Hydrobromide:
  • < 1 month: 0.0% - (0 of 1 people)
  • 1 - 6 months: 50.0% - (1 of 2 people)
  • 6 - 12 months: 0.0% - (0 of 5 people)
  • 1 - 2 years: 50.0% - (2 of 4 people)
  • 2 - 5 years: 100.0% - (1 of 1 people)
  • 5 - 10 years: 0.0% - (0 of 1 people)
  • 10+ years: 0.0% - (0 of 1 people)
  • not specified: 0.0% - (0 of 0 people)
Marijuana:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 33.0% - (1 of 3 people)
  • 6 - 12 months: 50.0% - (2 of 4 people)
  • 1 - 2 years: 100.0% - (1 of 1 people)
  • 2 - 5 years: 50.0% - (1 of 2 people)
  • 5 - 10 years: 100.0% - (1 of 1 people)
  • 10+ years: 100.0% - (3 of 3 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Citalopram Hydrobromide:
  • female: 0.0% - (0 of 8 people)
  • male: 57.0% - (4 of 7 people)
Marijuana:
  • female: 71.0% - (5 of 7 people)
  • male: 57.0% - (4 of 7 people)

Drug effectiveness by age:

Citalopram Hydrobromide:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 33.0% - (1 of 3 people)
  • 20-29: 20.0% - (1 of 5 people)
  • 30-39: 20.0% - (1 of 5 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 1 people)
  • 60+: 100.0% - (1 of 1 people)
Marijuana:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 33.0% - (1 of 3 people)
  • 20-29: 75.0% - (3 of 4 people)
  • 30-39: 60.0% - (3 of 5 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 100.0% - (1 of 1 people)
  • 60+: 100.0% - (1 of 1 people)

Most common drug interactions over time *:

< 1 month:
  • dizziness
  • drug abuse
  • affective disorder
  • altered state of consciousness
  • amnesia
  • anxiety
  • aphagia
  • balance disorder
  • blindness transient
  • euphoric mood
1 - 6 months:
  • aggression
  • antisocial behaviour
  • cramps - menstrual
  • death
  • disinhibition
  • dissociation
  • homicide
  • nausea
  • personality change
  • physical assault
6 - 12 months:
  • aggression
  • bruxism
  • anxiety
  • confusion
  • cramps - menstrual
  • depression
  • dissociative identity disorder
  • hot flush
  • major depression
  • mania
2 - 5 years:
  • arteriosclerosis coronary artery
  • death
  • emphysema
  • hostility
  • hypertensive heart disease
  • mood swings
  • obesity
  • tobacco user
5 - 10 years:
  • anxiety, apprehension, feeling uptight, jitters, stress, stress and anxiety, tension
  • obsessive rumination
  • tremor
  • anxiety
  • arteriosclerosis coronary artery
  • confusion
  • death
  • depression
  • diabetic neuropathy
  • dissociative identity disorder
10+ years:
  • anxiety, apprehension, feeling uptight, jitters, stress, stress and anxiety, tension
  • diabetes mellitus
  • diabetes mellitus inadequate control
  • diabetic neuropathy
  • hyperglycaemia
  • hypoglycaemia
  • neuropathy peripheral
  • obsessive rumination
  • tremor
  • type 1 diabetes mellitus
not specified:
  • depression
  • suicidal ideation
  • fall
  • pain
  • abdominal pain upper
  • acute coronary syndrome
  • constipation
  • dyspepsia
  • hiatus hernia
  • bone disorder

Most common drug interactions by gender *:

female:
  • cardio-respiratory arrest
  • respiratory arrest
  • cardiac arrest
  • death
  • depression
  • completed suicide
  • electrocardiogram qt prolonged
  • electrocardiogram st segment abnormal
  • fall
  • hypokalaemia
male:
  • aggression
  • feeling abnormal
  • fatigue
  • homicide
  • diabetes mellitus
  • disinhibition
  • dissociation
  • mood altered
  • restlessness
  • diabetic neuropathy

Most common drug interactions by age *:

0-1:
  • foetal exposure during pregnancy
  • foetal malformation
  • maternal drugs affecting foetus
  • somnolence
  • somnolence neonatal
10-19:
  • aggression
  • hallucination, auditory
  • homicide
  • disinhibition
  • dissociation
  • dreamy state
  • cardiac arrest
  • feeling abnormal
  • respiratory arrest
  • accidental exposure
20-29:
  • aggression
  • akathisia
  • death
  • cardio-respiratory arrest
  • drug dependence
  • restlessness
  • suicide attempt
  • depression
  • fatigue
  • mood altered
30-39:
  • electrocardiogram qt prolonged
  • electrocardiogram st segment abnormal
  • hypokalaemia
  • fall
  • liver function test abnormal
  • somnolence
  • acute coronary syndrome
  • alanine aminotransferase increased
  • aspartate aminotransferase increased
  • cardio-respiratory arrest
40-49:
  • chest pain
  • completed suicide
  • suicidal ideation
  • abdominal pain upper
  • anxiety
  • back pain
  • blood cholesterol increased
  • bronchitis
  • chills
  • chronic obstructive pulmonary disease
50-59:
  • completed suicide
  • multiple sclerosis relapse
  • pneumonia
  • hyperhidrosis
  • tachycardia
  • clostridium difficile colitis
  • dehydration
  • diabetes mellitus
  • diabetes mellitus inadequate control
  • diabetic neuropathy
60+:
  • disease recurrence
  • dry mouth
  • neuropathy peripheral
  • somnolence

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Citalopram hydrobromide and Marijuana?

Can you answer these questions?

More questions for: Citalopram hydrobromide, Marijuana

You may be interested in these reviews

More reviews for: Citalopram hydrobromide, Marijuana

On eHealthMe, Citalopram hydrobromide (citalopram hydrobromide) is often used to treat depression. Marijuana (marijuana) is often used to treat drug abuse and dependence. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.